chinese glp-1 Semaglutide weight loss indication approved in China Novo Nordisk's diet drug may

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in people with diabetes.

GLP-1 receptor agonists can support weight loss across different target amounts, including modest 10-pound goals

From a pharma strategy perspective, this is a prudent and timely regulatory signal

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this strategy may not be effective for everyone.

Conversely, RNA interference (i)-induced knockdown of SIRT1 attenuated the lipolytic and oxidative responses to exendin-4 in differentiated 3T3-L1 adipocytes

Lose weight & control blood sugar